Will New Obesity Drugs Make Bariatric Surgery Obsolete?September 17, 2024ObesityBusiness of MedicineDiabetesHypercortisolism
Autoimmune Disease Risk May Rise Following Cushing Disease Remission After SurgeryFebruary 22, 2024Pituitary, Thyroid & Adrenal DisordersHypercortisolism
Depression strikes more than half of obese adolescentsApril 22, 2022ObesityHypercortisolismPediatrics
FDA approves levoketoconazole for Cushing syndromeJanuary 5, 2022HypercortisolismPituitary, Thyroid & Adrenal DisordersRare DiseasesReproductive Endocrinology
COVID-19 pandemic affects menstrual cycles, presenting challenges for conceptionOctober 21, 2021Reproductive EndocrinologyHypercortisolism
Cushing’s death rate ‘unacceptable,’ triple that of general populationApril 21, 2021HypercortisolismLipid DisordersPituitary, Thyroid & Adrenal Disorders
Metyrapone for Cushing’s syndrome: Safe, effective in first testMarch 24, 2021HypercortisolismPituitary, Thyroid & Adrenal DisordersMixed Topics
Endocrine-disrupting plastics pose growing health threatDecember 15, 2020Reproductive EndocrinologyMixed TopicsHypercortisolism
First-of-its kind guideline on lipid monitoring in endocrine diseasesNovember 6, 2020Pituitary, Thyroid & Adrenal DisordersLipid DisordersDiabetesHypercortisolismMenopauseMen's HealthReproductive Endocrinology
Cortisol levels on COVID-19 admission may be a marker of severityJune 23, 2020COVID-19 UpdatesHypercortisolism
